141 filings
Page 4 of 8
8-K
u78w2v04n
9 Sep 21
Regulation FD Disclosure
6:13am
8-K
or0hfdr7c3f5kto
24 Aug 21
Other Events
9:07am
8-K
5m8yl5yd0v qhm
5 Aug 21
Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:06am
8-K
pby6qntj0v w78r
3 Jun 21
Submission of Matters to a Vote of Security Holders
8:01am
8-K
ut02 rerl8qzmg
1 Jun 21
Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat
6:08am
8-K
pun932d74rqa0ngd26
10 May 21
Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:11am
8-K
15cxq1 63c
30 Mar 21
Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of
9:07am
8-K
jft54
25 Feb 21
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides
8:04am
8-K
p2fr7jhouz200tu k9
18 Feb 21
Departure of Directors or Certain Officers
8:03am
8-K
kp3tvlvcxjkkb7jl
17 Feb 21
Entry into a Material Definitive Agreement
4:06pm
8-K
qddt9
28 Jan 21
Departure of Directors or Certain Officers
4:29pm
8-K
fg0vnpfg8abo4g3uuwww
12 Jan 21
Regulation FD Disclosure
7:06am
8-K
uvohrr5vyrl tba04f
15 Dec 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:22am
8-K
nhexv0m75
2 Dec 20
Entry into a Material Definitive Agreement
4:17pm
8-K
x4wv2v4
5 Nov 20
Akebia Reports Third Quarter 2020 Financial Results and Recent Business Updates
8:15am
8-K
nyouxfo
25 Sep 20
Other Events
8:16am
8-K
sab3nx 1ff
11 Sep 20
Entry into a Material Definitive Agreement
5:00pm
8-K
a5t ax52owo9
3 Sep 20
Akebia Therapeutics Announces Top-Line Results from its PRO2TECT Global Phase 3 Program of
4:55pm
8-K
wxlyyxny
10 Aug 20
Akebia Reports Second Quarter 2020 Financial Results
4:02pm
8-K
q4l2w7 02oo39
18 Jun 20
Departure of Directors or Certain Officers
4:16pm